Log In
Print
BCIQ
Print
Print this Print this
 

BMN-190

  Manage Alerts
Collapse Summary General Information
Company BioMarin Pharmaceutical Inc.
DescriptionTripeptidyl peptidase 1 (TPP1) enzyme replacement therapy
Molecular Target Tripeptidyl peptidase 1 (TPP1)
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase I/II
Standard Indication Neurology (unspecified)
Indication DetailsTreat late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today